Is Dolby Laboratories Inc (NYSE:DLB) Going to Burn These Institutional Investors?

July 17, 2017 - By Marie Mckinney

 Is Dolby Laboratories Inc (NYSE:DLB) Going to Burn These Institutional Investors?

Sentiment for Dolby Laboratories Inc (NYSE:DLB)

Dolby Laboratories Inc (NYSE:DLB) institutional sentiment increased to 1.46 in 2016 Q4. Its up 0.33, from 1.13 in 2016Q3. The ratio has improved, as 140 funds increased or started new equity positions, while 96 reduced and sold stock positions in Dolby Laboratories Inc. The funds in our partner’s database reported: 50.18 million shares, down from 51.52 million shares in 2016Q3. Also, the number of funds holding Dolby Laboratories Inc in their top 10 equity positions was flat from 4 to 4 for the same number . Sold All: 28 Reduced: 68 Increased: 86 New Position: 54.

Dolby Laboratories, Inc. designs and makes audio and imaging products for the cinema, television, broadcast and entertainment industries. The company has market cap of $5.52 billion. The Company’s products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It has a 29.17 P/E ratio. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

About 488,190 shares traded or 70.78% up from the average. Dolby Laboratories, Inc. (NYSE:DLB) has risen 14.35% since July 17, 2016 and is uptrending. It has underperformed by 2.35% the S&P500.

Analysts await Dolby Laboratories, Inc. (NYSE:DLB) to report earnings on July, 26. They expect $0.65 earnings per share, 0.00 % or $0.00 from last year’s $0.65 per share. DLB’s profit will be $66.34 million for 20.77 P/E if the $0.65 EPS becomes a reality. After $0.47 actual earnings per share reported by Dolby Laboratories, Inc. for the previous quarter, Wall Street now forecasts 38.30 % EPS growth.

Crestwood Capital Management L.P. holds 5.32% of its portfolio in Dolby Laboratories, Inc. for 310,300 shares. Price Michael F owns 928,255 shares or 5.09% of their US portfolio. Moreover, Nantahala Capital Management Llc has 4.35% invested in the company for 927,907 shares. The Louisiana-based Diversified Investment Strategies Llc has invested 3.15% in the stock. Timucuan Asset Management Inc Fl, a Florida-based fund reported 704,240 shares.#img1#

Since January 1, 0001, it had 0 insider purchases, and 13 sales for $5.12 million activity.

Dolby Laboratories, Inc. (NYSE:DLB) Ratings Coverage

Ratings analysis reveals 25% of Dolby Laboratories’s analysts are positive. Out of 4 Wall Street analysts rating Dolby Laboratories, 1 give it “Buy”, 0 “Sell” rating, while 3 recommend “Hold”. The lowest target is $38 while the high is $54. The stock’s average target of $46.25 is -14.35% below today’s ($54) share price. DLB was included in 5 notes of analysts from October 22, 2015. As per Thursday, January 28, the company rating was upgraded by Dougherty & Company. The firm has “Neutral” rating given on Thursday, October 22 by B. Riley & Co. JP Morgan downgraded the stock to “Neutral” rating in Friday, April 8 report. The stock of Dolby Laboratories, Inc. (NYSE:DLB) has “Hold” rating given on Friday, July 14 by Piper Jaffray. Dougherty & Company maintained it with “Buy” rating and $54 target in Thursday, April 28 report.

More notable recent Dolby Laboratories, Inc. (NYSE:DLB) news were published by: which released: “Ex-Dolby Labs IP Exec Launches Sex Bias Suit” on July 08, 2017, also with their article: “Dolby Laboratories (DLB) Q2 2017 Results – Earnings Call Transcript” published on April 27, 2017, published: “BRIEF-Dolby Laboratories and Netflix partner to deliver the first global …” on June 28, 2017. More interesting news about Dolby Laboratories, Inc. (NYSE:DLB) were released by: and their article: “Dolby: An Overlooked Growth Story With Catalysts” published on January 05, 2017 as well as‘s news article titled: “Dolby Laboratories: An Impressive Q1, But Price And Dilution Remain Concerns” with publication date: January 26, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.